Dental Management of Patients With HIV in Pays de la Loire
Condition(s) studied
Investigational drug(s) / intervention(s)
HIV infection status and clinical characteristics: Observational assessment of clinical, biological, and comorbidity data in patients living with HIV, including CD4 count, viral load, hematological parameters, and associated conditions, collected from routine care without any intervention.
Study summary
Dental care for people living with HIV has evolved with the widespread use of antiretroviral therapy, which has improved life expectancy and disease control. However, uncertainty remains about whether specific adaptations are still needed during dental procedures due to potential biological abnormalities that may increase infectious or bleeding risks.
This study aims to evaluate the proportion of patients living with HIV in the Pays de la Loire region who may require adapted dental management based on biological parameters such as immune status, hematological values, and comorbidities.
A retrospective descriptive study will be conducted using anonymized data from 5,603 patients followed in the COREVIH Pays de la Loire database. The results are expected to provide objective data to better inform dental practice and reduce unnecessary precautions or stigmatization in the management of patients living with HIV.
Eligibility
Primary outcome measure(s)
- Proportion of Patients Requiring Adapted Dental Management — At time of data extraction (retrospective baseline)
Percentage of patients living with HIV presenting at least one biological abnormality associated with increased risk of infectious or hemorrhagic complications during invasive dental procedures, including low CD4 count, neutropenia, thrombocytopenia, or anemia, based on routinely collected clinical data.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Nantes-Department of Dentistry | Nantes | Nantes | Recruiting |
More Nantes University Hospital trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07552038 on ClinicalTrials.gov ↗ ← All trials in France